![]() ![]() Other experts have also raised the third point, about the variant’s potential to reduce the effectiveness of monoclonal antibody treatments. Jeremy Kamil, from the Louisiana State University Health Sciences Center, suggested to the BBC that “Delta plus might have a slight advantage at infecting and spreading between people who were previously infected earlier during the pandemic or who have weak or incomplete vaccine immunity.”īut he also noted that this is not much different from the delta variant. ![]() This mutation, however, is present in other variants, as well, so it is likely not a new source of concern.Īdditionally, virologist Dr. A mutation in the protein may strengthen this interaction, which could increase transmissibility, as per these first two points. ![]() The spike protein is responsible for binding to a cell’s surface receptors, allowing the virus to enter. potential reduction in monoclonal antibody response.stronger binding to receptors of lung cells.INSACOG lists the following concerns regarding the delta plus variant: Yet, “Delta and other circulating variants of concern remain a higher public health risk, as they have demonstrated increases in transmission,” the WHO added.įurthermore, since India has labeled this variant a “variant of concern,” the country’s SARS-CoV-2 Consortium on Genomics (INSACOG), which is made up of 28 laboratories dedicated to whole genome sequencing of the SARS-CoV-2 virus and its evolving variants, continues to follow the evolution of delta plus. The WHO shared with Reuters that “For the moment, this variant does not seem to be common, currently accounting for only a small fraction of the delta sequences.” ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |